These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

170 related items for PubMed ID: 16873705

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. MTHFR gene polymorphism is susceptible to diabetic retinopathy but not to diabetic nephropathy in Japanese type 2 diabetic patients.
    Maeda M, Yamamoto I, Fukuda M, Motomura T, Nishida M, Nonen S, Fujio Y, Kasayama S, Azuma J.
    J Diabetes Complications; 2008; 22(2):119-25. PubMed ID: 18280442
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Association between sorbitol dehydrogenase gene polymorphisms and type 2 diabetic retinopathy.
    Szaflik JP, Majsterek I, Kowalski M, Rusin P, Sobczuk A, Borucka AI, Szaflik J, Blasiak J.
    Exp Eye Res; 2008 Apr; 86(4):647-52. PubMed ID: 18289528
    [Abstract] [Full Text] [Related]

  • 7. Cardiovascular disease, mortality, and retinal microvascular characteristics in type 1 diabetes: Wisconsin epidemiologic study of diabetic retinopathy.
    Klein BE, Klein R, McBride PE, Cruickshanks KJ, Palta M, Knudtson MD, Moss SE, Reinke JO.
    Arch Intern Med; 2004 Sep 27; 164(17):1917-24. PubMed ID: 15451768
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. PAI-1 4G/5G insertion/deletion promoter polymorphism and microvascular complications in type 2 diabetes mellitus.
    Funk M, Endler G, Exner M, Marculescu R, Endler L, Abrahamian H, Mauler H, Grimm A, Raith M, Mannhalter C, Prager R, Irsigler K, Wagner OF.
    Wien Klin Wochenschr; 2005 Oct 27; 117(19-20):707-10. PubMed ID: 16416371
    [Abstract] [Full Text] [Related]

  • 10. Association of the Leu72Met polymorphism of the ghrelin gene with the risk of Type 2 diabetes in subjects with impaired glucose tolerance in the Finnish Diabetes Prevention Study.
    Mager U, Lindi V, Lindström J, Eriksson JG, Valle TT, Hämäläinen H, Ilanne-Parikka P, Keinänen-Kiukaanniemi S, Tuomilehto J, Laakso M, Pulkkinen L, Uusitupa M, Finnish Diabetes Prevention Study Group.
    Diabet Med; 2006 Jun 27; 23(6):685-9. PubMed ID: 16759313
    [Abstract] [Full Text] [Related]

  • 11. Toll-like receptor 4 gene polymorphism and early onset of diabetic retinopathy in patients with type 2 diabetes.
    Buraczynska M, Baranowicz-Gaszczyk I, Tarach J, Ksiazek A.
    Hum Immunol; 2009 Feb 27; 70(2):121-4. PubMed ID: 19135114
    [Abstract] [Full Text] [Related]

  • 12. A polymorphic CA repeat in the IGF-I gene is associated with gender-specific differences in body height, but has no effect on the secular trend in body height.
    Rietveld I, Janssen JA, van Rossum EF, Houwing-Duistermaat JJ, Rivadeneira F, Hofman A, Pols HA, van Duijn CM, Lamberts SW.
    Clin Endocrinol (Oxf); 2004 Aug 27; 61(2):195-203. PubMed ID: 15272914
    [Abstract] [Full Text] [Related]

  • 13. The - 429 T/C and - 374 T/A gene polymorphisms of the receptor of advanced glycation end products gene are not risk factors for diabetic retinopathy in Caucasians with type 2 diabetes.
    Globocnik Petrovic M, Steblovnik K, Peterlin B, Petrovic D.
    Klin Monbl Augenheilkd; 2003 Dec 27; 220(12):873-6. PubMed ID: 14704946
    [Abstract] [Full Text] [Related]

  • 14. A common polymorphism in the promoter of the IGF-I gene associates with increased fasting serum triglyceride levels in glucose-tolerant subjects.
    Nielsen EM, Hansen L, Lajer M, Andersen KL, Echwald SM, Urhammer SA, Hansen T, Pedersen O.
    Clin Biochem; 2004 Aug 27; 37(8):660-5. PubMed ID: 15302607
    [Abstract] [Full Text] [Related]

  • 15. The G-250A substitution in the promoter region of the hepatic lipase gene is associated with the conversion from impaired glucose tolerance to type 2 diabetes: the STOP-NIDDM trial.
    Zacharova J, Todorova BR, Chiasson JL, Laakso M, STOP-NIDDM Study Group.
    J Intern Med; 2005 Feb 27; 257(2):185-93. PubMed ID: 15656877
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Retinal vessel diameters and cerebral small vessel disease: the Rotterdam Scan Study.
    Ikram MK, De Jong FJ, Van Dijk EJ, Prins ND, Hofman A, Breteler MM, De Jong PT.
    Brain; 2006 Jan 27; 129(Pt 1):182-8. PubMed ID: 16317022
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Homocysteine, S-adenosylmethionine and S-adenosylhomocysteine are associated with retinal microvascular abnormalities: the Hoorn Study.
    Van Hecke MV, Dekker JM, Nijpels G, Teerlink T, Jakobs C, Stolk RP, Heine RJ, Bouter LM, Polak BC, Stehouwer CD.
    Clin Sci (Lond); 2008 Apr 27; 114(7):479-87. PubMed ID: 17956228
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.